Lara Zakaria, PharmD, MS, CNS, FMCP, illustrates the breadth of health technology going in and out of community pharmacy practice.
News|Articles|May 3, 2024
OTC Product Roundup: In a Galaxy Far, Far Away…
Author(s)Lauren Massaro
Are you a Wookie with a mane to maintain or a scoundrel prone to nausea? You don’t have to traverse distant planets to find OTC recommendations that meet your needs—this guide has you covered.
Advertisement
READ MORE:
Advertisement
Related to this article
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
In the second part of our interview with a collection of pharmacists from various backgrounds, they delve into the current developments highlighting the future of the profession.
Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.
The finalized rule is another step in the right direction for pharmacies calling for reform due to underwater reimbursement and other PBM pressures.
Allison Schneider, MPH, provides a detailed update regarding pharmacies’ impact within Medicare price negotiations and the legislation further impacting businesses.
The US health department announced policies that will allow for the compounding of 6 key peptides in US pharmacies.
Advertisement
Advertisement
Trending on Drug Topics
1
Updated Diabetes Consensus Shifts Focus from Glucose Control to Whole-Person Care
2
HHS Lets Pharmacies Compound Peptides as FDA Writes Official Rule
3
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
4
COVID-19, Flu Shots Coadministered Are Well-Tolerated in Pregnancy
5